Key result
Key cellular processes of glomerulosclerosis have been sufficiently defined to enable the deduction of potential therapies and the planning of future clinical trials.
Key points are not available for this paper at this time.
Design
Review
May inform targeted trial design in glomerulosclerosis; extends mechanistic insights but leaves clinical translation open.
The burgeoning literature on glomerulosclerosis makes frequent review of the literature necessary. At this stage, the key processes involved have surely been defined. It is now appropriate to make deductions about possible therapies and to plan experiments and trials.
No takes yet. Share an insight, caveat, or question.
E. Nigel Wardie (1994) studied this question. Key cellular processes of glomerulosclerosis have been sufficiently defined to enable the deduction of potential therapies and the planning of future clinical trials.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: